Dr. Reddy's Laboratories Ltd. (RDY)

38.26
0.19 0.49
NYSE : Health Technology
Prev Close 38.45
Open 38.26
Day Low/High 38.22 / 38.47
52 Wk Low/High 29.00 / 42.82
Volume 26.04K
Avg Volume 160.10K
Exchange NYSE
Shares Outstanding 166.06M
Market Cap 6.47B
EPS 1.60
P/E Ratio 23.45
Div & Yield 0.29 (0.72%)
Dr. Reddy’s Announces The Launch Of LEVALBUTEROL INHALATION SOLUTION, USP

Dr. Reddy’s Announces The Launch Of LEVALBUTEROL INHALATION SOLUTION, USP

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Levalbuterol Inhalation Solution, USP 0.

Trade-Ideas: Dr Reddy Laboratories (RDY) Is Today's New Lifetime High Stock

Trade-Ideas: Dr Reddy Laboratories (RDY) Is Today's New Lifetime High Stock

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

India Is Still Surging

The entire universe of Indian equities seems reasonably priced.

New Lifetime High For Dr Reddy Laboratories (RDY)

New Lifetime High For Dr Reddy Laboratories (RDY)

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

3 Stocks Dragging The Health Care Sector Downward

3 Stocks Dragging The Health Care Sector Downward

TheStreet highlights 3 stocks pushing the health care sector lower today.

Dr. Reddy’s Q1 FY15 Financial Results

Dr. Reddy’s Q1 FY15 Financial Results

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy's To Release Q1 FY15 Results On July 30, 2014

Dr. Reddy's To Release Q1 FY15 Results On July 30, 2014

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting.

Dr Reddy Laboratories Ltd Stock Upgraded (RDY)

Dr Reddy Laboratories Ltd Stock Upgraded (RDY)

Dr Reddy Laboratories (NYSE:RDY) has been upgraded by TheStreet Ratings from a hold to buy.

Ratings Changes Today

Upgrades: FFBC, GRT, GTS, QEP, RDY Downgrades: None Initiations: EPZM, FRBA, KMDA Read on to get TheStreet Quant Ratings' detailed report:

Dr. Reddy’s Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy’s Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy’s Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2014 was filed with the ...

Dr. Reddy’s Announces The Launch Of Duloxetine Delayed-Release Capsules USP

Dr. Reddy’s Announces The Launch Of Duloxetine Delayed-Release Capsules USP

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA ® (Duloxetine ...

Dr. Reddy’s Announces The Launch Of Paricalcitol Capsules

Dr. Reddy’s Announces The Launch Of Paricalcitol Capsules

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Paricalcitol Capsules, 1 mcg, 2 mcg and 4 mcg, a therapeutic equivalent generic version of ZEMPLAR ® (Paricalcitol) Capsules in the...

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Tread Carefully If Trying to Ride India's Rally

Tread Carefully If Trying to Ride India's Rally

Indian markets have rallied to record highs on the election of a new government pledging economic reform, but fund managers warn of pitfalls when investing in the world's second-most-populous nation.

Dr Reddy Laboratories Ltd Stock Downgraded (RDY)

Dr Reddy Laboratories Ltd Stock Downgraded (RDY)

Dr Reddy Laboratories (NYSE:RDY) has been downgraded by TheStreet Ratings from from a buy to hold.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

Ratings Changes Today

Upgrades: CHRW, CPWR, ECA, FENG, SMIT, SUNS, TOF, ZTS Downgrades: AMRI, CDI, CWCO, EGY, ESIO, IFON, OESX, RDY, SLRC, TRR Initiations: JMI Read on to get TheStreet Quant Ratings' detailed report:

Senior Level Changes At Dr. Reddy’s

Senior Level Changes At Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy’s Q4 & FY14 Financial Results

Dr. Reddy’s Q4 & FY14 Financial Results

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy's To Release Q4 And Full Year FY14 Results On May 13, 2014

Dr. Reddy's To Release Q4 And Full Year FY14 Results On May 13, 2014

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Fourth Quarter and Full year ended March 31, 2014 on Tuesday, May 13, 2014 after the Board Meeting.

Try these 7 rallying Indian stocks as country gears up for elections

Try these 7 rallying Indian stocks as country gears up for elections

James Dennin, Kapitall: Could these 7 rallying Indian stocks keep their momentum through election season, or do they portend correction? The [...]

Dr. Reddy’s Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg

Dr. Reddy’s Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Fenofibrate Capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of ANTARA ® (fenofibrate) capsules, in the US...

Dr. Reddy’s Announces The Launch Of Eszopiclone Tablets C-IV

Dr. Reddy’s Announces The Launch Of Eszopiclone Tablets C-IV

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA® (eszopiclone) tablets C-IV in the ...

Dr. Reddy Laboratories Ltd. Stock Upgraded (RDY)

Dr. Reddy Laboratories Ltd. Stock Upgraded (RDY)

Dr. Reddy Laboratories (NYSE:RDY) has been upgraded by TheStreet Ratings from a hold to buy.

Ratings Changes Today

Upgrades: EPIQ, EXAR, GCAP, RDY Downgrades: EXA, IDRA, NCMI, PENN, SLW Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Dr. Reddy’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets

Dr. Reddy’s Announces The Launch Of Amlodipine Besylate And Atorvastatin Calcium Tablets

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.

Dr. Reddy’s Announces The Launch Of Moxifloxacin Hydrochloride Tablets

Dr. Reddy’s Announces The Launch Of Moxifloxacin Hydrochloride Tablets

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy’s Announces The Launch Of Sumatriptan Injection USP, Autoinjector System

Dr. Reddy’s Announces The Launch Of Sumatriptan Injection USP, Autoinjector System

Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.

New Lifetime High For Dr. Reddy Laboratories (RDY)

New Lifetime High For Dr. Reddy Laboratories (RDY)

Trade-Ideas LLC identified Dr. Reddy Laboratories (RDY) as a new lifetime high candidate

3 Stocks Pushing The Drugs Industry Downward

3 Stocks Pushing The Drugs Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

TheStreet Quant Rating: C (Hold)